Showing 1 - 4 of 4
Biotech breakthrough in virus vaccines
Life, Thana Boonlert, Published on 12/04/2022
» The National Centre for Genetic Engineering and Biotechnology (Biotec) recently announced the success of developing a pseudotyped virus for a Covid-19 vaccine and drug trials.
Debunking the endgame theory
Life, Thana Boonlert, Published on 18/01/2022
» Like all viruses, SARS-CoV-2 adapts for survival. First identified in South Africa in November, the new variant of concern, Omicron, has now swept across the world. It carries a large number of mutations, including those on the spike protein, which are thought to increase transmissibility. However, studies have found that it causes milder infection than previous variants.
A win for health security
Life, Thana Boonlert, Published on 08/11/2021
» What is inside a tube can be the matter of life and death. Scientists carefully transfer each patient's sample into a microplate and put it in an automated box-shaped extraction instrument. After processing it for 10 minutes, it isolates ribonucleic acid (RNA) from coronavirus cells for an RT-PCR test.
Shot in the dark
Life, Thana Boonlert, Published on 19/01/2021
» It took less than a year to come up with what would normally take a decade to achieve, but the endeavour to formulate a coronavirus vaccine was made possible because of the publication of the entire genetic code of the coronavirus, which first emerged in the city of Wuhan.